Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shijiazhuang Xingbai Pharma Receives $18 Million Investment from Infinity

publication date: Mar 1, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shijiazhuang Xingbai Pharmaceutical Company of Hebei, a maker of biological pesticides, received a private equity investment of 120 million RMB ($18.3 million) from Israel-based Infinity. The financing is meant to increase Shijiazhuang Xingbai’s biotech capabilities, as the company makes plans for an IPO in the A-share market in three years. More details....

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners